指南与共识临床免疫质量管理与危急值分子诊断

AACC关于在临床实验室实施和解读SARS-CoV-2紧急使用授权及实验室自建血清学检测的实用建议

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories.
指南 / 共识 · Clin Chem · 2021-01-01

美国临床化学协会(AACC)召集临床化学、微生物学、免疫学实验室、体外诊断行业及监管机构专家,针对SARS-CoV-2血清学检测(EUA及LDT)的实施与解读提出实用建议。内容涵盖检测平台、抗体类型(含中和抗体)、体液免疫应答、验证与确认、质量管理、四种检测指征、结果解读与报告注释及正交检测的作用,旨在为实验室专业人员和医护人员提供 comprehensive 参考。

要点

  • AACC专家小组针对SARS-CoV-2血清学EUA和LDT检测提出实施与解读建议。
  • 建议涵盖检测验证、质量管理、四种检测指征及结果报告与正交检测。
  • 文件旨在指导临床实验室在疫情期间合理应用血清学检测并解读结果。

核心结论

  • 该文件为实验室专业人员和医护人员在临床实验室中适当实施SARS-CoV-2血清学检测并解读结果提供综合参考。

研究设计与样本

  • AACC召集临床化学、微生物学、免疫学实验室、体外诊断行业及监管机构专家组成小组制定建议。

主要发现

  • 讨论了当前可用的EUA血清学检测和平台、检测设计信息、抗体类别(包括中和抗体)及对SARS-CoV-2的体液免疫应答。
  • 描述了EUA和LDT检测的验证与确认以及质量管理方法。
  • 列出了血清学检测的四种指征。
  • 提出了结果解读、报告注释及正交检测作用的建议。

临床怎么用

  • 实验室专业人员可依据本建议实施SARS-CoV-2血清学检测并解读结果。
  • 在规划未来类似疫情(如媒介传播或呼吸道病原体暴发)时可参考本文件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical laboratory continues to play a critical role in managing the coronavirus pandemic. Numerous US Food and Drug Administration emergency use authorization (EUA) and laboratory-developed test (LDT) serologic assays have become available. The performance characteristics of these assays and their clinical utility continue to be defined in real time during this pandemic. The AACC convened a panel of experts from clinical chemistry, microbiology, and immunology laboratories; the in vitro diagnostics industry; and regulatory agencies to provide practical recommendations for implementation and interpretation of these serologic tests in clinical laboratories. CONTENT: The currently available EUA serologic tests and platforms, information on assay design, antibody classes including neutralizing antibodies, and the humoral immune responses to SARS-CoV-2 are discussed. Verification and validation of EUA and LDT assays are described, along with a quality management approach. Four indications for serologic testing are outlined. Recommendations for result interpretation, reporting comments, and the role of orthogonal testing are also presented. SUMMARY: This document aims to provide a comprehensive reference for laboratory professionals and healthcare workers to appropriately implement SARS-CoV-2 serologic assays in the clinical laboratory and to interpret test results during this pandemic. Given the more frequent occurrence of outbreaks associated with either vector-borne or respiratory pathogens, this document will be a useful resource in planning for similar scenarios in the future.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Zhang YV, Wiencek J, Meng QH, et al. AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories. Clin Chem. 2021. PMID: 34470034. doi:10.1093/clinchem/hvab051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。